Barclays
NXGN

Barclays’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Barclays’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-87,444
Closed -$2.08M – 5430
2023
Q3 		$2.08M Buy
87,444
+30,802
+54% +$580K ﹤0.01% 1873
2023
Q2 		$919K Sell
56,642
-126
-0.2% -$2.09K ﹤0.01% 2365
2023
Q1 		$988K Buy
56,768
+2,993
+6% +$53.8K ﹤0.01% 2738
2022
Q4 		$1.01M Sell
53,775
-3,171
-6% -$61.1K ﹤0.01% 2789
2022
Q3 		$1.01M Sell
56,946
-9,067
-14% -$157K ﹤0.01% 2227
2022
Q2 		$1.15M Sell
66,013
-18,062
-21% -$344K ﹤0.01% 2236
2022
Q1 		$1.76M Sell
84,075
-31,223
-27% -$598K ﹤0.01% 1967
2021
Q4 		$2.05M Buy
115,298
+20,577
+22% +$330K ﹤0.01% 2365
2021
Q3 		$1.33M Buy
94,721
+60,410
+176% +$940K ﹤0.01% 2608
2021
Q2 		$570K Sell
34,311
-64,426
-65% -$1.15M ﹤0.01% 3009
2021
Q1 		$1.79M Buy
98,737
+36,224
+58% +$715K ﹤0.01% 2382
2020
Q4 		$1.14M Sell
62,513
-13,370
-18% -$212K ﹤0.01% 2660
2020
Q3 		$966K Buy
75,883
+18,384
+32% +$235K ﹤0.01% 2725
2020
Q2 		$631K Buy
57,499
+15,399
+37% +$160K ﹤0.01% 3156
2020
Q1 		$439K Sell
42,100
-39,069
-48% -$504K ﹤0.01% 3692
2019
Q4 		$1.3M Buy
81,169
+4,321
+6% +$71.4K ﹤0.01% 3427
2019
Q3 		$1.2M Sell
76,848
-18,113
-19% -$301K ﹤0.01% 3482
2019
Q2 		$1.89M Buy
94,961
+53,098
+127% +$992K ﹤0.01% 2987
2019
Q1 		$705K Buy
41,863
+10,688
+34% +$185K ﹤0.01% 3790
2018
Q4 		$472K Sell
31,175
-40,181
-56% -$689K ﹤0.01% 3865
2018
Q3 		$1.43M Buy
71,356
+41,810
+142% +$886K ﹤0.01% 3274
2018
Q2 		$576K Buy
29,546
+9,616
+48% +$152K ﹤0.01% 3812
2018
Q1 		$272K Sell
19,930
-2,252
-10% -$29.7K ﹤0.01% 4560
2017
Q4 		$301K Sell
22,182
-8,084
-27% -$116K ﹤0.01% 4340
2017
Q3 		$476K Buy
30,266
+1,338
+5% +$21.6K ﹤0.01% 3680
2017
Q2 		$498K Sell
28,928
-7,739
-21% -$118K ﹤0.01% 3535
2017
Q1 		$559K Sell
36,667
-9,365
-20% -$138K ﹤0.01% 3295
2016
Q4 		$605K Buy
46,032
+38,429
+505% +$492K ﹤0.01% 3199
2016
Q3 		$87K Sell
7,603
-17,548
-70% -$211K ﹤0.01% 4607
2016
Q2 		$299K Sell
25,151
-10,445
-29% -$140K ﹤0.01% 3630
2016
Q1 		$533K Buy
35,596
+5,611
+19% +$85.1K ﹤0.01% 3100
2015
Q4 		$479K Sell
29,985
-14,290
-32% -$209K ﹤0.01% 3257
2015
Q3 		$532K Sell
44,275
-13,559
-23% -$186K ﹤0.01% 3292
2015
Q2 		$926K Buy
57,834
+28,195
+95% +$454K ﹤0.01% 2946
2015
Q1 		$444K Buy
29,639
+10,261
+53% +$170K ﹤0.01% 3702
2014
Q4 		$290K Buy
19,378
+9,134
+89% +$134K ﹤0.01% 4342
2014
Q3 		$134K Sell
10,244
-21,917
-68% -$333K ﹤0.01% 5092
2014
Q2 		$514K Buy
32,161
+19,337
+151% +$306K ﹤0.01% 3947
2014
Q1 		$204K Buy
12,824
+3,025
+31% +$54.9K ﹤0.01% 4774
2013
Q4 		$206K Sell
9,799
-241,493
-96% -$5.44M ﹤0.01% 4987
2013
Q3 		$5.28M Buy
251,292
+215,990
+612% +$4.61M 0.01% 1637
2013
Q2 		$661K Buy
+35,302
New +$644K ﹤0.01% 3889

Other funds holding NXGN

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's NXGN Position: Q4 2023 in Review

Barclays sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 87,444 shares — an estimated $2.08M sold.

Barclays first reported a position in NXGN in Q2 2013 and held it in 42 quarters. The position peaked at $5.28M in Q3 2013. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • Barclays reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Barclays sold 87,444 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $2.08M.
  • Barclays first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
  • Barclays's NextGen Healthcare, Inc. Common Stock position peaked at $5.28M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.